New Delhi: Researchers at the National Institute of Technology (NIT) Rourkela have developed a bioink made from natural ...

D Bioprinting Market The global 3D bioprinting market is set to grow from USD 2.78 Bn in 2025 to USD 7.39 Bn by 2032, registering a CAGR o ...

The research team at NIT Rourkela has developed a bioink that remains in liquid form at room temperature but quickly turns ...

A research team has successfully developed an innovative platform for diabetes treatment using bioink derived from pancreatic ...

In a significant breakthrough in biomedical engineering, researchers at the National Institute of Technology (NIT) Rourkela have developed an innovative natural bioink aimed at enhancing 3D ...

Prof. Devendra Verma's team at NIT Rourkela have developed a groundbreaking bioink for efficient 3D bioprinting in bone ...

Diabetes is a metabolic disorder caused by dysfunction in the pancreas, the organ responsible for regulating blood sugar levels. Within the pancreas, islet cells secrete insulin to lower blood sugar.

The Zhejiang University team developed a multi-material projection-based 3D bioprinting (PBBP) system employing a synergistic cleaning strategy called "fluid-controlled rinsing with negative ...

Three-dimensional (3D) bioprinting technology has revolutionized regenerative medicine by enabling the generation of engineered and functional 3D organs or tissues, including adipose tissues.

3D bioprinting is a technology that uses 3D printing to create tissues and organs from living cells and biomaterials. Photo / 123rf In the new science fiction film Mickey 17, Robert Pattinson’s ...

Food printing has been around for a while, but some experiments have taken it to strange new places. Scientists and chefs ...